rxstat › Prices in Saskatchewan › Sevelamer

Sevelamer (Renagel) price and coverage in Saskatchewan

Sevelamer 800 mg tablet lists at $1.86 per tablet in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Sevelamer is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

How it compares across Canada

800 mg Tablet, lowest listed price in each province.

New Brunswick$1.26/tablet
Nova Scotia$1.26/tablet
Alberta$1.86/tablet
Saskatchewan$1.86/tablet

Price by strength in Saskatchewan

Strength and formLowest priceBrand
800 mg Tablet1 product · special approval$1.86/tablet–
All 1 products listed in Saskatchewan
ProductPriceCoverage
800 mg Tablet
RenagelAVT · DIN 02244310$1.86/tabletSpecial approval

What you'll pay at the pharmacy

These are the prices the Saskatchewan Drug Plan lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.

Shortage status

No active shortage is reported for Sevelamer in Canada. Full drug page.

Sevelamer price in other provinces

Common questions

How much does Sevelamer cost in Saskatchewan?

Sevelamer 800 mg tablet lists at $1.86 per tablet in Saskatchewan on the Saskatchewan Drug Plan's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Is Sevelamer covered in Saskatchewan?

Sevelamer is covered by the Saskatchewan Drug Plan only under Exception Drug Status (EDS): your prescriber has to request coverage, and it applies to patients who meet set criteria.

Is Sevelamer cheaper in another province?

For 800 mg tablet, listed prices run from $1.26 to $1.86 across 3 provinces. Public plans only cover their own residents, though.

Source: Saskatchewan Drug Plan Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.